Form 483

B. Braun Medical, Inc. Form 483, 2015-09-21

FDA issued a Form 483 to B. Braun Medical, Inc. on 2015-09-21 with 10 public-safe observations.

483· Form 483 issuedHuman Drugs10 observations

B. Braun Medical, Inc. · Allentown, United States · Issued September 21, 2015

Overview

  • 10 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Sep 2015
21 CFR 211.165(a)

Testing and release for distribution

Cited by Gayle S Lawson

21 Sep 2015
21 CFR 211.165(a)

Testing and release for distribution

Cited by Gayle S Lawson

21 Sep 2015
21 CFR 211.166(a)

Lack of written stability program

Cited by Gayle S Lawson

21 Sep 2015
21 CFR 211.166(a)

Lack of written stability program

Cited by Gayle S Lawson

21 Sep 2015
21 CFR 211.166(b)

Adequate number of batches on stability

Cited by Gayle S Lawson

Inspected site

BBB. Braun Medical, Inc.Allentown, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(a)Cited across public-safe Form 483 observations2x
21 CFR 211.166(a)Cited across public-safe Form 483 observations2x
21 CFR 211.166(b)Cited across public-safe Form 483 observations2x
21 CFR 211.170(b)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere